Adaptive designs offer numerous advantages in the context of cancer trials:
Efficiency Improvement: By allowing modifications based on interim data, adaptive designs can reduce the time and cost of clinical trials. Ethical Considerations: These designs can minimize patient exposure to ineffective treatments by enabling early trial termination. Flexibility: Researchers can adjust the trial to focus on the most promising treatments, potentially improving patient outcomes.
